Paragon Biosciences Evozyne Capital, LLC — Form D

Paragon Biosciences Evozyne Capital, LLC of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-07. The offering totals $9.5M, of which $9.5M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2020-05-07
• Form: D
• Accession: 0001811339-20-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $9.5M
• Amount sold: $9.5M
• Investors: 2
• Date of first sale: 2020-04-27
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-366520

Issuer

• Name: Paragon Biosciences Evozyne Capital, LLC
• CIK: 0001811339
• Entity type: Limited Liability Company
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 330 N. WABASH AVENUE, CHICAGO, IL, 60611
• Phone: 312-847-1322

Officers, directors & promoters (3)

More

• CIK 1811339 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search